Straumann Holding Ag · SIX:STMN

Straumann — Q1 2026 Earnings Presentation

20 slides from Straumann's earnings presentation, Apr 29, 2026

  1. Slide 1: First-Quarter Results 2026

    2026 FIRST-QUARTER RESULTS Presentation for investors, analysts and media Basel, 29 April 2026

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation contains forward-looking statements, including statements regarding the beliefs, expectations and assumptions of future results, performance or achievements of Straumann Group, that are based upon information available to Straumann Group as of the date such statements ar

  3. Slide 3: Agenda

    AGENDA 1 Performance overview Guillaume Daniellot 2 Financial performance Isabelle Wege 3 Strategy update Guillaume Daniellot 4 2026 outlook Guillaume Daniellot 5 Q&A Guillaume Daniellot & Isabelle Wege 3

  4. Slide 4: Q1 Performance Overview

    Q1 PERFORMANCE OVERVIEW – Guillaume Daniellot, Group CEO – 4

  5. Slide 5: Strong Start into the Year

    STRONG START INTO THE YEAR Continuous market share gains First quarter revenue in CHF Organic revenue growth1 Regional performance 673 m 7.1 % North america Winning share in all key or -1.2% in CHF Growth across all businesses market segments Implantology Orthodontics Outlook 20262 High-single digit

  6. Slide 6: Solid Growth Across Regions with Varied Market Dynamics

    SOLID GROWTH ACROSS REGIONS WITH VARIED MARKET DYNAMICS NAM EMEA Q1 7.7% Q1 7.8% Q1 25 1.8% 26 %* 43 %* Q1 25 10.0% GROUP Q1 7.1% Q1 25 11.0% 22 %* LATAM Q1 19.5% 9 %* APAC Q1 25 18.8% Q1 0.5% Q1 25 23.0% 6 * % of Q1 2026 Group total revenue

  7. Slide 7: Q1 Financial Performance

    Q1 FINANCIAL PERFORMANCE – Isabelle wEge, Group CFO – 7

  8. Slide 8: Strong Results with Considerable FX Headwinds

    STRONG RESULTS WITH CONSIDERABLE FX HEADWINDS Revenue development breakdown in CHF million, rounded Regional % share of organic growth -1.2% 681 +7.1% 2 Organic APAC 10 673 23 LATAM 13 1 21 28 NAM 628 -53 0 Change in organic growth 47 EMEA +7.8% +7.7% +0.5% +19.5% Revenue FX effect M&A effect Adjust

  9. Slide 9: Operational Investments Driving Efficiency

    OPERATIONAL INVESTMENTS DRIVING EFFICIENCY • Shanghai campus fully ramped up, supporting cost efficiency and reducing FX exposure • Ongoing optimization of the global manufacturing network, driven by automation investment and a continued improvement mindset New Shanghai Campus fully operational Oper

  10. Slide 10: Strategy Update

    STRATEGY UPDATE – Guillaume Daniellot, Group CEO – 10

  11. Slide 11: 14% Market Share in a Large and Growing CHF 20bn Market

    14% MARKET SHARE IN A LARGE AND GROWING CHF 20BN MARKET Perform Transform Implantology Clear aligner Market size Market size >35% (+1%) CHF 6.1BN <5% CHF 4.9BN Market share Market share RegenerativeS Digital equipment Market size Market size <13% CHF 1.3BN >10% (+5%) CHF 1.8BN Market share Market sh

  12. Slide 12: Perform – Supporting iEXCEL Momentum with Innovation

    PERFORM – SUPPORTING IEXCEL MOMENTUM WITH INNOVATION Innovation: New differentiated innovations will only be available on iEXCEL • Launch of iGuide enabling guided surgery for full-arch treatments, expanding into high-value indications • Continuous expansion with new prosthetic solutions with a new

  13. Slide 13: Perform – Strengthening Clinical Education and Engagement

    PERFORM – STRENGTHENING CLINICAL EDUCATION AND ENGAGEMENT ITI: Leading global AOMI: new global implantology specialist network Network • Global network for evidence-based education and • Straumann supporting AOMI (Academy for Oral & research Maxillofacial Implantology), newly launched network focuse

  14. Slide 14: Transform – Strong Progress in Orthodontics Transformation

    TRANSFORM – STRONG PROGRESS IN ORTHODONTICS TRANSFORMATION innovation: boosted clearcorrect value proposition • Integrated CBCT visualization strengthening treatment planning and differentiation • Outcome simulation and automated case assessment improving patient communication and case acceptance •

  15. Slide 15: Transform – Very Strong Adoption of SIRIOS X3

    TRANSFORM – VERY STRONG ADOPTION OF SIRIOS X3 SIRIOS X3 Expanded intraoral scanner indications IOS portfolio – multi branding & multi pricing 3Shape Premium TRIOS 5/6 New advanced material Mid SIRIOS X3 Inlays & onlays feature Entry SIRIOS Screw-retained crowns • Strong IOS momentum thanks to new SI

  16. Slide 16: 2026 Outlook

    2026 OUTLOOK – Guillaume Daniellot, Group CEO – 16

  17. Slide 17: Outlook 2026 – Well-Positioned

    OUTLOOK 2026 – WELL- POSITIONED 1  Expected volatility and regulatory • High-single digit organic revenue environment to persist growth  Resilient business model with strong market positions • 30 to 60 basis points improvement  Highly engaged, entrepreneurial culture of the core EBIT margin at co

  18. Slide 18: Any Questions?

    ANY QUESTIONS? 18

  19. Slide 19: Calendar of Upcoming Events

    CALENDAR OF UPCOMING EVENT 2026 Event Location 5-6 May France & UK Roadshow – Jefferies Paris, London 7 May Italy Roadshow – Equita Milan 26-27 May Deutsche Bank European Champions Conference Frankfurt 27-28 May Stifel Jaws & Paws Conference New York 9-10 Jun Oddo Swiss Equity Conference Interlaken

  20. Slide 20: Thank You.

    THANK YOU. 20

Straumann Group — Q1 2026 Earnings Presentation on 6ix